Research and applications across a range of disease areas to improve allocative efficiency (the maximisation of health outcomes using the most cost-effective mix of interventions and implementation methods).

Optima models have been used extensively to address investment choices related to numerous areas including HIV/AIDS, tuberculosis, malaria, viral hepatitis, and nutrition.

Modelling groups affiliated with the Optima Consortium are continuing to extend the Optima approach, by developing new applications to inform investment of publicly-funded benefits packages for entire health systems, and for optimising implementation options across diverse sectors.

optimamodel.com